General Information
Sanofi LPS14584
A 24-week, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of Toujeo® and Tresiba® in Insulin-Naive Patients with Type 2 Diabetes Mellitus not Adequately Controlled with Oral Antidiabetic Drug(s) ± GLP-1 receptor agonist
| Protocol | LPS14584 |
|---|---|
| Identifier | Site No: 840-081 |
| UID | 0501a6dd-c29e-4e2a-bb15-bad3bce29d53 |
| Status | Done - Archived |
| Phase | 4 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2016 |
| NCT Number | - |
| Created | 2016-03-30 11:07 |
| Last Updated | 2016-03-30 11:07 |
Description
No description provided.
Comment
PCRS
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2016-10-25 | No |
| Enrollment Open | 2016-07-26 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2016-07-20 | No |
| PI Meeting Start | 2016-06-23 | No |
| PI Meeting End | 2016-06-25 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2017-11-15 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | - | No | |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Perez, Myrna | MPerez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Sanofi-Aventis |
|---|---|
| Division | Sanofi-Aventis |
| Team | Sanofi-Aventis |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
